Filed: 5/14/2025ACC: 0001214659-25-007553
📋 What this filing means
TCG CROSSOVER MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $733.09M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$733.09M
Total AUM (reported)
122.48M
Total Shares
Allocation by class
COMM$615.67M84.0%
ADRS$117.41M16.0%
Portfolio Concentration
Top 3$173.17M23.6%
4–10$232.23M31.7%
11–25$269.90M36.8%
Rest$57.79M7.9%
Top 3 weight
23.6%
Top 10 weight
55.3%
Voting Authority Distribution
Total shares with voting rights: 122.48M
Sole
Full voting authority
122.48M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings38
Rows:
CG ONCOLOGY INC
SOLEShares3.67M
TypeSH
Market value$89.88M
12.26%
Sole
3.67M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares6.96M
TypeSH
Market value$41.72M
5.69%
Sole
6.96M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.89M
TypeSH
Market value$41.57M
5.67%
Sole
2.89M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares2.47M
TypeSH
Market value$39.23M
5.35%
Sole
2.47M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares5.32M
TypeSH
Market value$38.99M
5.32%
Sole
5.32M
Shared
0.00
None
0.00
ABIVAX SA AMERICAN DEPOSITARY SHARES
SOLEShares6.06M
TypeSH
Market value$37.85M
5.16%
Sole
6.06M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares12.36M
TypeSH
Market value$34.24M
4.67%
Sole
12.36M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.65M
TypeSH
Market value$27.72M
3.78%
Sole
2.65M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.50M
TypeSH
Market value$27.24M
3.72%
Sole
1.50M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares2.90M
TypeSH
Market value$26.95M
3.68%
Sole
2.90M
Shared
0.00
None
0.00
XENCOR INC
SOLEShares2.45M
TypeSH
Market value$26.09M
3.56%
Sole
2.45M
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares465.26K
TypeSH
Market value$23.10M
3.15%
Sole
465.26K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares1.48M
TypeSH
Market value$22.47M
3.07%
Sole
1.48M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares1.01M
TypeSH
Market value$21.67M
2.96%
Sole
1.01M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares5.94M
TypeSH
Market value$21.04M
2.87%
Sole
5.94M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares275K
TypeSH
Market value$19.65M
2.68%
Sole
275K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares3.57M
TypeSH
Market value$19.36M
2.64%
Sole
3.57M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares1.06M
TypeSH
Market value$18.40M
2.51%
Sole
1.06M
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares2.80M
TypeSH
Market value$17.15M
2.34%
Sole
2.80M
Shared
0.00
None
0.00
RAPT Therapeutics, Inc.
SOLEShares13.09M
TypeSH
Market value$15.97M
2.18%
Sole
13.09M
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares5.25M
TypeSH
Market value$15.12M
2.06%
Sole
5.25M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares2.76M
TypeSH
Market value$14.75M
2.01%
Sole
2.76M
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares10.74M
TypeSH
Market value$14.71M
2.01%
Sole
10.74M
Shared
0.00
None
0.00
COMPASS PATHWAYS LTD
SOLEShares3.86M
TypeSH
Market value$11.03M
1.51%
Sole
3.86M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.42M
TypeSH
Market value$9.40M
1.28%
Sole
1.42M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COMM | 3.67M | SH | $89.88M 12.26% | 3.67M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COMM | 6.96M | SH | $41.72M 5.69% | 6.96M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | ADRS | 2.89M | SH | $41.57M 5.67% | 2.89M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COMM | 2.47M | SH | $39.23M 5.35% | 2.47M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COMM | 5.32M | SH | $38.99M 5.32% | 5.32M | 0.00 | 0.00 |
ABIVAX SA AMERICAN DEPOSITARY SHARESSOLE | ADRS | 6.06M | SH | $37.85M 5.16% | 6.06M | 0.00 | 0.00 |
SAVARA INCSOLE | COMM | 12.36M | SH | $34.24M 4.67% | 12.36M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COMM | 2.65M | SH | $27.72M 3.78% | 2.65M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COMM | 1.50M | SH | $27.24M 3.72% | 1.50M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COMM | 2.90M | SH | $26.95M 3.68% | 2.90M | 0.00 | 0.00 |
XENCOR INCSOLE | COMM | 2.45M | SH | $26.09M 3.56% | 2.45M | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COMM | 465.26K | SH | $23.10M 3.15% | 465.26K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COMM | 1.48M | SH | $22.47M 3.07% | 1.48M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COMM | 1.01M | SH | $21.67M 2.96% | 1.01M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COMM | 5.94M | SH | $21.04M 2.87% | 5.94M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COMM | 275K | SH | $19.65M 2.68% | 275K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COMM | 3.57M | SH | $19.36M 2.64% | 3.57M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | ADRS | 1.06M | SH | $18.40M 2.51% | 1.06M | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COMM | 2.80M | SH | $17.15M 2.34% | 2.80M | 0.00 | 0.00 |
RAPT Therapeutics, Inc.SOLE | COMM | 13.09M | SH | $15.97M 2.18% | 13.09M | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COMM | 5.25M | SH | $15.12M 2.06% | 5.25M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COMM | 2.76M | SH | $14.75M 2.01% | 2.76M | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COMM | 10.74M | SH | $14.71M 2.01% | 10.74M | 0.00 | 0.00 |
COMPASS PATHWAYS LTDSOLE | ADRS | 3.86M | SH | $11.03M 1.51% | 3.86M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COMM | 1.42M | SH | $9.40M 1.28% | 1.42M | 0.00 | 0.00 |
Page 1 of 2